--- title: Cryo-EM Consultancy for Drug Discovery | cryoDuck B.V. description: Boost your drug discovery with our cryo-EM consultancy services and solutions. We empower the biotech landscape, from end-users to investors. image: https://cryoduck.com/hubfs/2.png --- [Skip to content](https://cryoduck.com#main-content) [![cryoDuck Logo](https://cryoduck.com/hs-fs/hubfs/Home/horizontal%20light%20bg.png?width=300&height=66&name=horizontal%20light%20bg.png)](https://cryoduck.com?hsLang=en) - [Home](https://cryoduck.com/) - [About](https://cryoduck.com/about) - [Blog](https://cryoduck.com/blog) - [Newsletter](https://cryoduck.com/newsletter) Open main navigation Close main navigation - [Home](https://cryoduck.com/) - [About](https://cryoduck.com/about) - [Blog](https://cryoduck.com/blog) - [Newsletter](https://cryoduck.com/newsletter) - [Contact us](https://cryoduck.com/contact) [Contact us](https://cryoduck.com/contact?hsLang=en) ## Your cryo-EM ducks in a row Consultancy and solutions for cryo-EM in drug discovery. [Get in touch](https://cryoduck.com/contact?hsLang=en) ![Cryo-EM ducks in a row](https://cryoduck.com/hubfs/cryoduck%20hero.png "Cryo-EM ducks in a row") ## For drug discovery, vendors, and VCs  Empowering the cryo-EM biotech landscape from end users to investors. ![Biotech](https://cryoduck.com/hubfs/Biotech.png "Biotech") ### Biotech & Pharma - Support of in-house platforms and outsourcing to CROs. - Gene-to-structure consultancy and solutions. - Partners for structure-to-drug. - Early access to innovation. ![Cryo-EM solutions](https://cryoduck.com/hubfs/Solution.png "Cryo-EM solutions") ### Cryo-EM vendors - Scientist-to-scientist marketing and business development. - Customer-centric and holistic product strategy. - Flexibility for strategic collaborations, application development, and ecosystem access. ![Biotech VCs](https://cryoduck.com/hubfs/VC.png "Biotech VCs") ### Venture Capital - Scientific consulting and networking for company creation. - Scientific due diligence and proof of concepts. - Development and integration of rational drug design platforms. [Receive our newsletter](https://cryoduck.com/newsletter?hsLang=en) ## End-to-end workflows Transforming point solutions into an encompassing cryo-EM success equation. ## Full cryo-EM platform development ## Next-gen applications ## EM-grade protein ## Grid preparation ## Electron microscopy ## Data processing ## Rational drug design ![Applications](https://cryoduck.com/hubfs/Applications.png "Applications") ![Protein](https://cryoduck.com/hubfs/Protein.png "Protein") ![Freeze](https://cryoduck.com/hubfs/Freeze.png "Freeze") ![EM1](https://cryoduck.com/hubfs/EM1.png "EM1") ![Processing-&-Data](https://cryoduck.com/hubfs/Processing-%26-Data.png "Processing-&-Data") ![CADD](https://cryoduck.com/hubfs/CADD.png "CADD") - ### Reduce time-to-structure and costs. - ### Improve resolution and structure throughput. - ### Maximize impact on must-win programs. [Learn more](https://cryoduck.com/about?hsLang=en) ![Duck ecosystem](https://cryoduck.com/hubfs/Duck%20ecosystem.png "Duck ecosystem") ## Exclusive and seamless: Ecosystem-wide collaboration • Benefit from alliances with best-in-breed solutions. • Harnessing collective strengths to accelerate innovation. • Conflict-free collaborations for trust and transparency. ## Across targets and modalities [Talk to us](https://cryoduck.com/contact?hsLang=en) ![Membrane-protein](https://cryoduck.com/hubfs/Membrane-protein.png "Membrane-protein") ##### Membrane proteins ##### Small molecules ![Small-molecule](https://cryoduck.com/hubfs/Small-molecule.png "Small-molecule") ![Small-protein](https://cryoduck.com/hubfs/Small-protein.png "Small-protein") ##### Small targets ##### Antibodies ![Biologics](https://cryoduck.com/hubfs/Biologics.png "Biologics") ![Large-protein1](https://cryoduck.com/hubfs/Large-protein1.png "Large-protein1") ##### Large complexes ##### New modalities ![New-modalities](https://cryoduck.com/hubfs/New-modalities.png "New-modalities") - Membrane proteins including GPCRs, ion channels, and solute transporters. - Small targets and large multi-subunit complexes. - Small molecules, antibodies, and emerging modalities including targeted protein degraders. # Stay connected: Follow and engage with us Contact form or email Get in touch with us by completing the [contact form](https://cryoduck.com/contact?hsLang=en) on our website or simply send us an email. ![Email](https://cryoduck.com/hs-fs/hubfs/Email.png?width=980&height=67&name=Email.png)   Bi-monthly newsletter Subscribe to our [bi-monthly newsletter](https://cryoduck.com/newsletter?hsLang=en) to receive a summary of recent developments and highlights. The cryoDuck Blog Follow [the cryoDuck Blog](https://cryoduck.com/the-cryoduck-blog?hsLang=en) for commentary on everything related to cryo-EM in drug discovery. LinkedIn group: Cryo-EM in pharma and biotech Join our [LinkedIn group community](https://www.linkedin.com/groups/8888430/) to network with industry professionals and engage in discussions pertaining to cryo-EM in industry.  LinkedIn company page Follow our [LinkedIn company page](https://www.linkedin.com/company/94199435/)  for company updates and latest contents. [![cryoDuck Logo](https://cryoduck.com/hs-fs/hubfs/Home/horizontal%20light%20bg.png?width=300&height=66&name=horizontal%20light%20bg.png "cryoDuck Logo")](https://cryoduck.com?hsLang=en) 5615EC 86, Netherlands --- [Contact](https://cryoduck.com/contact?hsLang=en) [Privacy and Cookies Policy](https://cryoduck.com/privacy-and-cookies-policies?hsLang=en) [Terms and Conditions](https://cryoduck.com/terms-and-conditions?hsLang=en) --- Copyright © 2026, cryoDuck B.V. Cookie Settings